1st International Oncology Treatment Forum Held in Foshan: Fosun Health Builds an International Academic Exchange Platform for Oncology
On September 19, 2026, the 1st International Oncology Treatment Forum, hosted by Fosun Health, opened in Foshan, Guangdong Province. Under the theme Advanced Medical Care, Safeguarding Lives, Full‑cycle Management, Igniting New Hope, the forum assembled more than 200 experts in oncology, radiation oncology and related disciplines from 15 countries and regions including the United States, Indonesia, Bangladesh, Pakistan and Russia. In‑depth discussions covered global advances in radiation oncology, national cancer‑care landscapes, precision radiotherapy, cell therapy, clinical‑trial design and international medical services. During the forum, the Global Oncology Collaboration Alliance was officially launched to foster regular collaboration among medical institutions, oncology specialists and professional resources across countries and regions.
International Oncology Forum Kicks Off in Foshan, Building a Platform for Global Academic Exchange
As a key component of the conference, themed sessions covered the full‑scope landscape of radiotherapy from the Radiosurgery Society (RSS); status of radiotherapy development across Indonesia, Bangladesh, Pakistan and China; functional radiosurgery; integrative innovative immunotherapy; stereotactic radiosurgery (SRS) for breast cancer; robotic CyberKnife radiosurgery; radionuclide‑ligand‑driven precision oncology; boron neutron capture therapy (BNCT); advances in CAR‑T cell therapy; ultrasound therapy for liver cancer; and application of appropriate traditional Chinese‑medicine techniques in full‑cycle oncology management. The forum also explored international patient journeys including tele‑consultation, cross‑border medical travel and insurance reimbursement.
Participating experts deliberated on expanded indications, optimized treatment strategies and real‑world clinical experience of precision radiotherapy for diverse tumour types, as well as synergistic combinations of radiation oncology with surgical and systemic therapies.
Hu Hang, Chairman & CEO of Fosun Health and Chairman of Foshan Fosun Chancheng Hospital, delivered opening‑session remarks: “Given the complexity of cancer diagnosis and treatment, no single country or institution can independently cover the full spectrum from basic research to clinical translation. Through this platform, we aim to translate cutting‑edge global academic findings into accessible, affordable patient‑centred diagnostic and therapeutic solutions anchored in academic excellence.”
Global Experts Share Cutting‑edge Progress to Boost Mutual Learning in Clinical Practice
Specialists from leading institutions presented clinical and research updates across radiotherapy, functional radiosurgery, immunotherapy, breast‑cancer SRS, robotic CyberKnife, radionuclide ligands, BNCT, CAR‑T, ultrasound liver‑cancer therapy and TCM‑integrated oncology. Participating organisations included the Radiosurgery Society (RSS), Cipto Mangunkusumo National General Hospital (Indonesia), National Institute of Cancer Research & Hospital (Bangladesh), Institute of Nuclear Medicine, Oncology and Radiotherapy (Pakistan), Russian Higher Medical School of Oncology, Duke University Medical Center, University of Maryland School of Medicine, The Sixth Affiliated Hospital of Sun Yat‑sen University, Chinese University of Hong Kong Hospital, Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital.
During the round‑table session, panellists discussed “China‑led solutions for international medical services: building an ecosystem to attract overseas patients”, exploring patient‑centred collaborative pathways for cross‑border healthcare.
Global Oncology Collaboration Alliance Established to Build Tele‑Consultation and Second‑Opinion Networks
One major milestone of the forum was the official launch of the Global Oncology Collaboration Alliance. By pooling resources from medical institutions and oncology specialists worldwide, the alliance will develop international collaborative frameworks, facilitate sharing of clinical experience, medical resources and specialist expertise, and gradually roll out an international network for tele‑consultation and Second Opinion services. Moving forward, alliance members will host online case conferences for complex and refractory malignancies, deliver multidisciplinary treatment recommendations, and explore streamlined patient referral and medical‑service collaboration mechanisms where applicable.
In medical education and clinical‑skill exchange, Fosun Health deepened partnerships with Vietnamese medical partners including Oriental Hospital, Hung Vuong Hospital and Truong Thang Oncology Clinic to advance continuing medical education (CME) and clinical‑skill transfer. Both sides will build multi‑layered cooperation frameworks covering short‑term clinical fellowships, remote case review, academic symposia and physician exchanges to share clinical know‑how across healthcare systems.
Shen Yun, Co‑President and General Manager of International Cooperation Department at Fosun Health, stated in her forum speech: “Internationalisation is not simply ‘going global’ or ‘bringing‑in’. It represents medical integration bound together by academic exchange and centred on patient needs. We want to shift from one‑off consultations toward end‑to‑end patient navigation, making cross‑border oncology care smoother and more humane.”
From One‑off Consultation to End‑to‑end Navigation: Exploring New Models for Cross‑border Healthcare
To address systemic barriers facing international oncology patients — including payment hurdles, visa logistics, language support, medical‑record translation and post‑treatment follow‑up — Fosun Health is rolling out an end‑to‑end navigation service model.
Pre‑treatment: Overseas patients submit medical records via overseas liaison offices or tele‑consultation platforms. Professional teams complete record translation and pre‑screening, with oncologists conducting preliminary clinical assessment.
In‑hospital: Multilingual patient escorts, dual‑physician care combining general practitioners and specialists, plus full multidisciplinary teamwork.
Post‑treatment: Scheduled remote follow‑up through tele‑medicine platforms. With patient consent and full regulatory compliance, medical records and imaging data are shared with local home‑country clinicians to deliver continuous “treatment in China + local follow‑up” care pathways.
For cross‑border payment, Fosun Health collaborates with global insurance partners including Prudential, AIA, Allianz, AXA, Cigna Global, Manulife and Asia Insurance to enable direct‑billing arrangements and multi‑currency settlement, reducing financial friction for patients. Secure encrypted transmission of medical records and imaging datasets via tele‑consultation platforms supports multidisciplinary joint review with overseas hospitals and local physicians. These initiatives aim to “let data travel instead of patients”, improving accessibility and continuity of cross‑border oncology care.
Forging Academic‑led, Patient‑centred Integration of Global Healthcare
Fosun Health’s four Greater‑Bay‑Area hospitals have cumulatively served more than 50 000 international patients originating from over 130 countries and regions. As one of Guangdong’s first pilot hospitals for international medical services and the only private‑sector participant in Foshan, Foshan Fosun Chancheng Hospital hosts a 20 000‑m² International Medical Centre with 100 planned inpatient beds, integrating outpatient, inpatient, health‑check and rehabilitation services under its dual‑physician “GP + specialist” clinical model. The hospital houses one of South China’s only 6th‑generation CyberKnife systems, complemented by cutting‑edge technologies including CAR‑T therapy and the da Vinci Surgical Robot, forming a closed‑loop clinical pathway from precision diagnosis to personalised treatment.
Looking ahead, Fosun Health will uphold its international brand proposition Advanced care, closer to you. Leveraging its domestic healthcare network and proven global‑cooperation experience, Fosun Health will deepen partnerships with medical institutions worldwide across oncology care, academic exchange and talent development. It will facilitate two‑way knowledge flows: bringing Chinese oncology solutions to the world while importing global insights into China. Anchored in academic excellence and patient‑first values, Fosun Health will join global peers to expand access to high‑quality oncology services and contribute to global human health.
Comments